Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Chou

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|March 15, 2014
Succinate dehydrogenase deficiency is rare in pituitary adenomasAnthony J Gill, Christopher W Toon, Adele Clarkson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma"Nicholas Kesby, Robert Mechera, Talia Fuchs, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2014
Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaFares Al-Ejeh, Marina Pajic, Wei Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2023
Natural History and Predictive Factors of Outcome in Medullary Thyroid MicrocarcinomaNicholas Kesby, Robert Mechera, Talia Fuchs, et al.
Human Pathology|March 19, 2010
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromesAnthony J Gill, Diana E Benn, Angela Chou, et al.
Pathology|June 20, 2020
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 casesTalia L Fuchs, Antonia Pearson, Justine Pickett, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 14, 2023
Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomasYomna S Abd El-Aziz, Matthew J McKay, Mark P Molloy, et al.
Journal of Translational Medicine|March 11, 2025
Automated deep learning-based assessment of tumour-infiltrating lymphocyte density determines prognosis in colorectal cancerJoshua Millward, Zhen He, Aiden Nibali, et al.
The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|March 15, 2014
Succinate dehydrogenase deficiency is rare in pituitary adenomasAnthony J Gill, Christopher W Toon, Adele Clarkson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma"Nicholas Kesby, Robert Mechera, Talia Fuchs, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2014
Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaFares Al-Ejeh, Marina Pajic, Wei Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2023
Natural History and Predictive Factors of Outcome in Medullary Thyroid MicrocarcinomaNicholas Kesby, Robert Mechera, Talia Fuchs, et al.
Human Pathology|March 19, 2010
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromesAnthony J Gill, Diana E Benn, Angela Chou, et al.
Pathology|June 20, 2020
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 casesTalia L Fuchs, Antonia Pearson, Justine Pickett, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 14, 2023
Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomasYomna S Abd El-Aziz, Matthew J McKay, Mark P Molloy, et al.
Journal of Translational Medicine|March 11, 2025
Automated deep learning-based assessment of tumour-infiltrating lymphocyte density determines prognosis in colorectal cancerJoshua Millward, Zhen He, Aiden Nibali, et al.
The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.
Pageof 12